Pacific Edge has announced that Medicare coverage of Cxbladder tests in the US market is expected to cease from 17 July 2023, resulting in a substantial reduction in revenue.
The company is exploring legal options and cost containment initiatives while seeking to regain coverage.
A conference call will be held today to discuss the matter.
See more
The S&P/NZX 50 Index closed at 13,072.93, up 5.1 points or 0.039%.
Experts are picking a surge in mergers and acquisitions activity for 2025.
Some stocks gave back some of their recent rises today.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details
